Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2023-03-07 00:00:00 ET · period of report 2023-02-28 · accession 0001209191-23-016842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-03 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +15.6K | 1.93M | +0.8% | — |
| D | 2023-03-07 | 2023-02-28 | DTIL | SMITH J. JEFFERSON | Chief Research Off | A - Grant | $0.95 | +12.2K | 1.91M | +0.6% | +$11.5K |
| D | 2023-03-07 | 2023-03-03 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | $0.00 | -15.6K | 31.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-03 | M | A | 15,576 | — | 1,930,207 | D | — | — | (F1) Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Common | Common Stock | 2023-02-28 | A | A | 12,157 | $0.95 | 1,914,631 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-03-03 | M | D | 15,576 | $0.00 | 31,144 | D | — · — to — | 15,576 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F3) On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |